Baker Brothers Life Sciences Capital (GP) LLC Baker Biotech Capital II (GP) LLC Baker Biotech Capital II (Z) (GP) LLC Baker Biotech Capital III (Z) (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
14159 capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2013-07-11 17:26:02 | 19,512,451 0 | 19,512,451 | Form 13D |
DELPHI MANAGEMENT PARTNERS VI LLC DELPHI VENTURES VI LP DELPHI BIOINVESTMENTS VI LP 10% Owner | 2007-01-19 19:49:32 | 1,980,200 2,000,000 | 3,980,200 | Form 4 |
JP MORGAN PARTNERS BHCA LP JPMP MASTER FUND MANAGER L P JPMP CAPITAL CORP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP GLOBAL INVESTORS L P 10% Owner | 2008-07-29 17:08:03 | 2,733,574 407,958 | 3,141,532 | Form 4 |
H&Q Holdings Inc. H&Q Employee Venture Fund 2000 L.P. 10% Owner | 2008-07-29 17:07:03 | 2,733,574 407,958 | 3,141,532 | Form 4 |
JP MORGAN PARTNERS BHCA LP JPMP MASTER FUND MANAGER L P JPMP CAPITAL CORP J P MORGAN CHASE & CO JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JPMP GLOBAL INVESTORS L P 10% Owner | 2008-07-21 16:20:29 | 2,263,980 0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP JPMP MASTER FUND MANAGER L P JP MORGAN PARTNERS GLOBAL INVESTORS LP JPMP CAPITAL LLC J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP JPMP GLOBAL INVESTORS L P 10% Owner | 2008-07-21 16:20:29 | 2,263,980 0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP JPMP GLOBAL INVESTORS L P JP MORGAN CHASE BANK JPMP CAPITAL CORP JPMP MASTER FUND MANAGER L P 10% Owner | 2008-07-21 16:20:29 | 2,263,980 0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP JPMP MASTER FUND MANAGER L P JPMP CAPITAL CORP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP JPMP GLOBAL INVESTORS L P 10% Owner | 2008-07-21 16:20:29 | 2,263,980 0 | 2,263,980 | Form 13D |
TrailSmith Pamela A Chief Scientific Officer | 2007-05-18 20:28:16 | 1,755,235 0 | 1,755,235 | Form 4 |
GALLEN JONATHAN Former 10% Owner | 2009-02-17 09:23:20 | 1,614,125 0 | 1,614,125 | Form 13G |
FELL H PERRY Chairman | 2003-12-02 18:58:42 | 1,294,000 0 | 1,294,000 | Form 4 |
SIEGALL CLAY B President & CEO | 2022-05-13 19:13:16 | 778,911 0 | 778,911 | Form 4 |
POWELL MICHAEL Director | 2004-12-16 18:40:49 | 20,001 647,577 | 667,578 | Form 4 |
BERGER FRANKLIN M Director | 2014-02-25 18:04:20 | 204,720 0 | 204,720 | Form 4 |
Reynolds Thomas C Chief Medical Officer | 2013-01-29 20:16:09 | 175,095 0 | 175,095 | Form 4 |
DOBMEIER ERIC Chief Operating Officer | 2017-12-06 20:04:46 | 144,560 0 | 144,560 | Form 4 |
BOERNER CHRISTOPHER S. Executive Vice President, Comm | 2014-08-27 16:22:43 | 112,358 0 | 112,358 | Form 4 |
Cline Darren S EVP, Commercial | 2018-11-30 18:32:35 | 72,556 0 | 72,556 | Form 4 |
SEELEY BRUCE J. EVP, Commerical | 2011-08-24 20:41:14 | 68,861 0 | 68,861 | Form 4 |
SENTER PETER Vice President, Chemistry | 2003-08-22 12:23:47 | 68,148 0 | 68,148 | Form 4 |
CARROLL TIM CFO | 2005-05-05 18:32:49 | 62,861 0 | 62,861 | Form 4 |
LIPPMAN MARC E Director | 2021-05-18 19:29:12 | 57,202 0 | 57,202 | Form 4 |
ROSENBERG MORRIS EVP, Process Sciences | 2012-06-14 19:51:20 | 54,077 0 | 54,077 | Form 4 |
SING AMY Sr. Director Medical Affairs | 2003-08-18 18:59:49 | 52,107 0 | 52,107 | Form 4 |
MCDONALD MICHAEL Chief Medical Officer | 2005-02-02 19:28:59 | 50,000 0 | 50,000 | Form 4 |
MCLAUGHLIN JOHN PETER Director | 2016-05-24 20:11:49 | 48,660 0 | 48,660 | Form 4 |
AKKARAJU SRINIVAS Director | 2020-05-19 19:10:02 | 44,674 0 | 44,674 | Form 4 |
TAYLOR ROBIN G Chief Commercial Officer | 2019-12-23 17:14:08 | 33,025 0 | 33,025 | Form 4 |
WILLIAMS DOUGLAS E CSO, EVP R&D | 2004-02-19 14:09:41 | 25,000 0 | 25,000 | Form 4 |
FBB2 LLC Director 10% Owner | 2012-06-18 17:38:49 | 18,243 0 | 18,243 | Form 3 |
Hoth Daniel Floyd JR Director | 2010-05-25 17:08:45 | 17,500 0 | 17,500 | Form 4 |
FBB3 LLC Director 10% Owner | 2014-12-11 17:02:34 | 12,678 0 | 12,678 | Form 3 |
DRACHMAN JONATHAN G See Remarks | 2018-03-22 21:36:51 | 10,526 0 | 10,526 | Form 4 |
SOUTHERN DOUGLAS Director | 2006-05-19 18:48:16 | 10,000 0 | 10,000 | Form 4 |
HELLSTROM KARL ERIK Director | 2004-05-18 15:11:44 | 10,000 0 | 10,000 | Form 4 |
BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 2023-12-18 18:46:48 | 0 0 | 0 | Form 4 |
HIMES VAUGHN B Chief Technical Officer | 2023-12-15 18:55:41 | 0 0 | 0 | Form 4 |
Simonian Nancy A Director | 2023-12-15 18:46:58 | 0 0 | 0 | Form 4 |
SIMPSON TODD E Chief Financial Officer | 2023-12-15 18:42:41 | 0 0 | 0 | Form 4 |
LOVE TED W Director | 2023-12-15 18:39:32 | 0 0 | 0 | Form 4 |
SWAIN SANDRA M Director | 2023-12-15 18:38:08 | 0 0 | 0 | Form 4 |
LIU JEAN I Chief Legal Officer | 2023-12-15 18:32:04 | 0 0 | 0 | Form 4 |
WELCH DANIEL G Director | 2023-12-15 18:31:12 | 0 0 | 0 | Form 4 |
Epstein David R CEO | 2023-12-15 18:29:19 | 0 0 | 0 | Form 4 |
Seth Alpna Director | 2023-12-15 18:24:45 | 0 0 | 0 | Form 4 |
GRYSKA DAVID W Director | 2023-12-15 18:16:57 | 0 0 | 0 | Form 4 |
ROMP CHARLES R EVP, Commercial U.S. | 2023-12-15 18:16:13 | 0 0 | 0 | Form 4 |
Orwin John A Director | 2023-12-15 18:10:54 | 0 0 | 0 | Form 4 |
DANSEY ROGER D President, R&D & CMO | 2023-12-15 18:10:33 | 0 0 | 0 | Form 4 |
CASCADE INVESTMENT LLC Formerly a 10% Owner | 2006-02-24 16:16:12 | 0 0 | 0 | Form 13G |
BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP 14159 L.P. Director 10% Owner | 2023-12-18 17:25:33 | 0 0 | 0 | Form 13D |